이 누리집은 대한민국 공식 전자정부 누리집입니다.
Biz News Korea(Eng)
SK Chemicals to import Parkinson`s drug from Portugal
- Collected
- 2018.03.05
- Distributed
- 2018.03.06
- Source
- Go Direct
![Jeon Kwang-Hyun, head of SK Chemicals’ pharmaceutical business, signs an exclusive agreement with António Portela, CEO of Portugal`s pharmaceutical company BIAL, to distribute the latter’s Parkinson’s therapy Ongentys across Korea in this picture taken at SK Chemicals’ Pangyo office in Gyeonggi Province. [photo by SK Chemical]](http://file.mk.co.kr/meet/neds/2018/03/image_readtop_2018_145385_15202303813227321.jpg)
Jeon Kwang-Hyun, head of SK Chemicals’ pharmaceutical business, signs an exclusive agreement with António Portela, CEO of Portugal`s pharmaceutical company BIAL, to distribute the latter’s Parkinson’s therapy Ongentys across Korea in this picture taken at SK Chemicals’ Pangyo office in Gyeonggi Province. [photo by SK Chemical]
Ongentys blocks one of the enzymes breaking down dopamine, helping extend the actions of drugs such as standard treatment levodopa that aims to increase the concentration of dopamine in the brain.
Patients treated with levodopa for a long time often experience movement fluctuations with reduced drug efficacy.
Ongentys indicated as an add-on therapy to preparations of levodopa boosts levodopa efficacy and improve related symptoms, according to the company.
SK Chemicals plans to file marketing approval for the drug in Korea in the first half of this year with a goal of launching in 2020.
“Ongentys will be an option to improve typical motor fluctuations of patients with Parkinson’s disease and we will be committed to improve public health by strengthening the portfolio of central nervous system medicines,” said an SK Chemicals official.
At 3:04 pm, SK Chemicals shares fell 1.88 percent to trade at 104,500 won on the Kospi market.
By Kim Hye-soon and Minu Kim
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]